COMMUNIQUÉS West-GlobeNewswire

Clearside Biomedical to Report Second Quarter 2019 Financial Results and Provide Corporate Update on Wednesday, August 7, 2019
31/07/2019
ALPHARETTA, Ga., July 31, 2019 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical company dedicated to developing treatments that restore and preserve vision for people with serious eye [...]
Profound Medical to Present at the Canaccord Genuity 39th Annual Growth Conference
31/07/2019
TORONTO, July 31, 2019 (GLOBE NEWSWIRE) -- Profound Medical Corp. (TSX:PRN; OTCQX:PRFMF) (“Profound” or the “Company”), the only company to provide customizable, incision-free therapies which combine real-time Magnetic [...]
CymaBay Therapeutics to Report Second Quarter 2019 Financial Results on Wednesday, August 7
31/07/2019
NEWARK, Calif., July 31, 2019 (GLOBE NEWSWIRE) -- CymaBay Therapeutics, Inc. (NASDAQ: CBAY), a clinical-stage biopharmaceutical company focused on developing therapies for liver and other chronic diseases with high [...]
Amedisys Reports Second Quarter 2019 Financial Results and Updates 2019 Guidance
31/07/2019
BATON ROUGE, La., July 31, 2019 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three and six-month periods ended June 30, 2019. Three Month Periods Ended June 30, 2019 and [...]
Adaptive Biotechnologies Receives New York State CLEP Approval for clonoSEQ to Detect and Monitor Minimal Residual Disease (MRD) in Patients with Certain Blood Cancers
31/07/2019
SEATTLE, July 31, 2019 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq:ADPT) (“Adaptive”), a commercial-stage biotechnology company that reads and translates the genetic code of the adaptive immune [...]
Inovalon Reports Second Quarter 2019 Results
31/07/2019
Second Quarter 2019 Highlights Q2 revenue of $157.0 million, up 3% year-over-year, and up 8% sequentially Q2 net income of $4.5 million, resulting in diluted net income of $0.03 per share Q2 Non-GAAP net income of $19.1 [...]
TRACON to Report Second Quarter 2019 Company Highlights and Financial Results on August 7, 2019
31/07/2019
SAN DIEGO, July 31, 2019 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (NASDAQ:TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted therapeutics for cancer [...]
ChromaDex to Report Second Quarter 2019 Financial Results on Wednesday, August 7, 2019
31/07/2019
LOS ANGELES, July 31, 2019 (GLOBE NEWSWIRE) -- ChromaDex Corp. (NASDAQ:CDXC) announced that it will hold a conference call on Wed., August 7, 2019 at 4:30 p.m. Eastern time to discuss its financial results for the [...]
Harpoon Therapeutics to Participate in Two Upcoming Investor Conferences
31/07/2019
SOUTH SAN FRANCISCO, Calif., July 31, 2019 (GLOBE NEWSWIRE) -- Harpoon Therapeutics, Inc. (NASDAQ: HARP), a clinical-stage immunotherapy company developing a novel class of T cell engagers, today announced that Gerald [...]
Conformis Reports Second Quarter 2019 Financial Results and Updates Product Revenue Expectations
31/07/2019
BILLERICA, Mass., July 31, 2019 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS), a medical technology company that uses its proprietary iFit Image-to-Implant technology platform to develop, manufacture and sell [...]
MyoKardia to Report Second Quarter 2019 Financial Results on Wednesday, August 7, 2019
31/07/2019
SOUTH SAN FRANCISCO, Calif., July 31, 2019 (GLOBE NEWSWIRE) -- MyoKardia, Inc. (Nasdaq: MYOK), today announced that it will report second quarter 2019 financial and operating results on Wednesday, August 7, 2019. [...]
PRA Health Sciences, Inc. Reports Second Quarter 2019 Results and Updates Full Year 2019 Guidance
31/07/2019
Net new business of $670.7 million; Net book-to-bill of 1.24 $763.3 million of total revenue; representing 5.6% growth at actual foreign exchange rates and 6.8% growth on a constant currency basis GAAP net income per [...]
CohBar to Announce 2019 Second Quarter Financial Results and Provide Business Update on August 7, 2019
31/07/2019
Company to host conference call and webcast at 5:00 p.m. ET MENLO PARK, Calif., July 31, 2019 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ: CWBR), a clinical stage biotechnology company developing mitochondria based [...]
Adamis Pharmaceuticals Announces Proposed Public Offering of Common Stock and Warrants
31/07/2019
SAN DIEGO, July 31, 2019 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (Nasdaq: ADMP), a specialty biopharmaceutical company focused on developing and commercializing products in various therapeutic areas, [...]
MacroGenics Provides Update on Corporate Progress and Second Quarter 2019 Financial Results
31/07/2019
Conference call scheduled for today at 4:30 p.m. ET ROCKVILLE, Md., July 31, 2019 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (NASDAQ: MGNX), a clinical-stage biopharmaceutical company focused on discovering and developing [...]
Nuvectra® Reports Second Quarter 2019 Financial Results
31/07/2019
PLANO, Texas, July 31, 2019 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ: NVTR), a neurostimulation medical device company, announced today financial results for the second quarter ended June 30, 2019. Recent [...]
Cara Therapeutics to Announce Second Quarter 2019 Financial Results on August 7, 2019
31/07/2019
STAMFORD, Conn., July 31, 2019 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq:CARA), a biopharmaceutical company focused on developing and commercializing new chemical entities designed to alleviate pruritus by [...]
Avinger Reports 26% Sequential Revenue Growth in Second Quarter 2019
31/07/2019
Revenue Growth Fuels Strong Operating Metrics Pantheris SV Limited Launch at Key U.S. Sites in July REDWOOD CITY, Calif., July 31, 2019 (GLOBE NEWSWIRE) -- Avinger, Inc. (Nasdaq: AVGR), a commercial-stage medical device [...]
Xenon Pharmaceuticals to Host Conference Call and Webcast to Discuss Second Quarter 2019 Financial Results and Provide Corporate Update
31/07/2019
BURNABY, British Columbia, July 31, 2019 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a clinical-stage biopharmaceutical company, today announced that it will report its second quarter 2019 financial [...]

Pages